Hospital Wiesbaden News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Retreatment with voxilaprevir/velpatasvir/sofosbuvir in patients with HCV and prior DAA failure is effective but may be impacted by hepatocellular carcinoma, cirrhosis, and genotype 3.

Wiesbaden christophJw goethe university hospitalWorld health organizationHospital wiesbadenChristoph sarrazinUniversity hospitalHepatitisc virusSustained virologic responseDirect acting antiviral